Villa Raffaella, Daidone Maria Grazia, Motta Rosita, Venturini Lorenza, De Marco Cinzia, Vannelli Alberto, Kusamura Shigeki, Baratti Dario, Deraco Marcello, Costa Aurora, Reddel Roger R, Zaffaroni Nadia
Department of Experimental Oncology and Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy.
Clin Cancer Res. 2008 Jul 1;14(13):4134-40. doi: 10.1158/1078-0432.CCR-08-0099.
This study aims to investigate the prevalence of the two known telomere maintenance mechanisms, telomerase activity (TA) and alternative lengthening of telomeres (ALT), and to assess their prognostic relevance in diffuse malignant peritoneal mesothelioma (DMPM).
In 44 DMPM specimens obtained from 38 patients, TA was determined using the telomeric repeat amplification protocol and ALT was detected by assaying ALT-associated promyelocytic leukemia nuclear bodies. The prognostic significance of telomere maintenance mechanisms was analyzed by Cox regression in the overall series and in a subset of 29 patients who underwent a uniform treatment regimen consisting of cytoreductive surgery and hyperthermic i.p. chemotherapy.
Telomere maintenance mechanisms were detectable in 86.4% of DMPM: ALT or TA alone was found in 18.2% or 63.6% of lesions, respectively, whereas two cases (4.6%) were ALT+/TA+. TA and ALT proved to be inversely associated (P = 0.002). In the overall series, TA was prognostic for 4-year relapse (TA+ versus TA-, hazard ratio, 3.30; 95% confidence interval, 1.23-8.86; P = 0.018) and cancer-related death (TA+ versus TA-, hazard ratio, 3.56; 95% confidence interval, 1.03-12.51; P = 0.045), whereas ALT failed to significantly affect clinical outcome. These results held true also in the subset of patients submitted to uniform treatment with cytoreductive surgery and hyperthermic i.p. chemotherapy.
Our results indicate that both known telomere maintenance mechanisms, TA and ALT, are present in DMPM and differentially affect patient prognosis.
本研究旨在调查两种已知的端粒维持机制——端粒酶活性(TA)和端粒的替代延长(ALT)的发生率,并评估它们在弥漫性恶性腹膜间皮瘤(DMPM)中的预后相关性。
从38例患者获取的44个DMPM标本中,使用端粒重复序列扩增法测定TA,通过检测与ALT相关的早幼粒细胞白血病核体来检测ALT。通过Cox回归分析在整个系列以及29例接受了包括细胞减灭术和腹腔内热化疗的统一治疗方案的患者亚组中端粒维持机制的预后意义。
在86.4%的DMPM中可检测到端粒维持机制:分别在18.2%或63.6%的病变中发现单独的ALT或TA,而2例(4.6%)为ALT+/TA+。TA和ALT被证明呈负相关(P = 0.002)。在整个系列中,TA对4年复发具有预后意义(TA+与TA-相比,风险比为3.30;95%置信区间为1.23 - 8.86;P = 0.018)以及癌症相关死亡(TA+与TA-相比,风险比为3.56;95%置信区间为1.03 - 12.51;P = 0.045),而ALT未能显著影响临床结局。这些结果在接受细胞减灭术和腹腔内热化疗统一治疗的患者亚组中也成立。
我们的结果表明,两种已知的端粒维持机制TA和ALT均存在于DMPM中,并对患者预后有不同影响。